NCT02614573

Brief Summary

The main objective of this study is to evaluate, for a 6-month observation period, the concordance in terms of clinical decision making concerning therapeutic adjustment as determined by a weekly capillary International Normalised Ratio (INR) monitoring strategy versus the usual strategy in a population of dependent elderly people in nursing homes, treated with anti-vitamin K (AVK).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 25, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2016

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 13, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 13, 2016

Completed
Last Updated

November 19, 2025

Status Verified

August 1, 2016

Enrollment Period

6 months

First QC Date

November 19, 2015

Last Update Submit

November 17, 2025

Conditions

Keywords

DependentAged, 80 and overAged

Outcome Measures

Primary Outcomes (1)

  • Is the capillary INR concordant with the venous INR ? yes/no

    Primary Outcome Measure as stated in protocol: Clinical concordances and clinical discrepancies between the capillary INR and venous INR every time they are concomitant

    6 months

Secondary Outcomes (5)

  • The number of thromboembolic events per patient

    6 months

  • The number of bleeding events per patient

    6 months

  • The number of thromboembolic or bleeding events per patient

    6 months

  • Coefficient of variation for capillary INR measures per patient

    6 months

  • Time in therapeutique range (days)

    6 months

Study Arms (1)

The study population

EXPERIMENTAL

The clinical phases of this study will be held in the nursing home (EHPAD; principal building + 2 annexes) of Pont-Saint-Esprit, located in France. Patients are elderly dependents treated by anti-vitamin K for more than 6 months.

Device: CoagucheckXSR Capillary INR measures

Interventions

We will be using the CoagucheckXSR device for capillary INR measures performed by nurses every 7 days during the 6 months of the study, plus after related intercurrent events. If capillary INR is \<2 or \>3 (with a tolerance of 1.9 to 3.1 given the margin of measurement inaccuracy of the coagulometer), then a classic venous measure is performed. If both tests agree, adaptation of treatment as indicated. If slightly discordant results, then the INR values are considered discordant and the decision to adjust the treatment dose and the next monitoring date for venous INR is made based on the value of the venous INR, according to the predefined protocol. If clinically significant discordance (\> 0.3), a venous INR is reperformed within 24 hours and if the discrepancy persists, dose adjustment is made according to the venous INR and the predefined protocol. If capillary INR is \> 4, then verification by venous measure and refer to general practitioner.

Also known as: CoagucheckXSR
The study population

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • The patient resides at the establishment for the dependent elderly (nursing home (EHPAD)) in Pont-Saint-Esprit, France
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient treated with vitamin K antagonist for over six months
  • The patient must have given his/her informed and signed consent
  • For adults under guardianship, the legal guardian must have given free and informed consent and signed the consent

You may not qualify if:

  • The patient is under judicial protection
  • The general practitioner in charge of the patient at the EHPAD does not want to participate in the study
  • It is impossible to correctly inform the patient, or his/her legal guardian
  • The patient, or his/her legal guardian, refuses to sign the consent
  • The patient is participating in another interventional study, or has participated in another interventional study within the past three months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

EHPAD de l'Hôpital de Pont Saint Esprit

Pont-Saint-Esprit, 30130, France

Location

Related Publications (1)

  • Sikirdji C, Costa D, Alonso S, Clape JF, Amouyal M, de Waziere B, Fabbro-Peray P. Assessment of agreement and time in therapeutic range of capillary versus venous international normalised ratio in frail elderly people in a nursing home. Intern Med J. 2019 Nov;49(11):1442-1446. doi: 10.1111/imj.14626.

Study Officials

  • Chloé Sikirdji, Interne

    Centre Hospitalier Universitaire de Nîmes

    STUDY DIRECTOR
  • Jean-François Clape, MD

    Centre Hospitalier Universitaire de Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2015

First Posted

November 25, 2015

Study Start

February 1, 2016

Primary Completion

August 13, 2016

Study Completion

August 13, 2016

Last Updated

November 19, 2025

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

Locations